Sign in

CIK 0001840229 · <br>Emerging growth company

MiNK Therapeutics, Inc.

Sign in to watch
Ticker
INKT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
212-994-8250
Business address
149 FIFTH AVENUE, SUITE 500, NEW YORK, NY, 10010
Former names
AgenTus Therapeutics, Inc., AgenTus Therapeutics, Inc.
  1. CORRESP Other Correspondence Between Filers and SEC Staff
  2. S-3/A Offering Registration Statement
  3. S-3 Offering Registration Statement
  4. 424B5 Offering Prospectus
  5. 424B5 Offering Prospectus
  6. 424B3 Offering Prospectus
  7. CORRESP Other Correspondence Between Filers and SEC Staff
  8. UPLOAD Other SEC-generated Letter
  9. S-3 Offering Registration Statement
  10. CORRESP Other Correspondence Between Filers and SEC Staff
  11. UPLOAD Other SEC-generated Letter
  12. S-3 Offering Registration Statement
  13. 424B4 Offering Prospectus
  14. CORRESP Other Correspondence Between Filers and SEC Staff
  15. CORRESP Other Correspondence Between Filers and SEC Staff
  16. S-1/A Offering Registration Statement
  17. CORRESP Other Correspondence Between Filers and SEC Staff
  18. S-1 Offering Registration Statement
  19. CORRESP Other Correspondence Between Filers and SEC Staff
  20. UPLOAD Other SEC-generated Letter

Page 1 of 2 · 22 filings